Eric A Md Rose
CIK 1139301 · Executive Chairman · last filed 2024-06-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
APOL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
7TH FLOOR
NEW YORK, NY 10032
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OBIO | Director | 7,544 | $5.81 | $43.8K | $0 | 5 | 2024-06-21 |
| ABIOMED INC (ABMD) Delisted | Director | 15,516 | $381.02 | $5.91M | -$280.0K | 10 | 2022-08-12 |
| SIGA | Director | 1,081,893 | $3.15 | $3.40M | -$595.6K | 31 | 2021-06-17 |
| ABIOMED INC (APOL) Delisted | Director | 21,259 | — | — | -$1.66M | 11 | 2016-12-02 |
| KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Director | 155,000 | — | — | $0 | 3 | 2008-11-18 |
| NEPHROS INC (NEP) Delisted | Director | — | $10.54 | — | $0 | 1 | 2007-05-24 |
Recent Filings · Page 3 of 7
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-08-28 | ABIOMED INC (ABMD) Delisted | Mixed | +22,042 | $170.6K | EDGAR |
| 2017-08-15 | ABIOMED INC (ABMD) Delisted | Tax (F) | −1,222 | -$185.0K | EDGAR |
| 2017-08-11 | ABIOMED INC (ABMD) Delisted | Mixed | +477 | -$125.6K | EDGAR |
| 2017-01-05 | SIGA | Mixed | +37,165 | -$86.4K | EDGAR |
| 2016-12-12 | SIGA | Mixed | +64,866 | -$214.3K | EDGAR |
| 2016-12-02 | ABIOMED INC (APOL) Delisted | Mixed | — | -$784.9K | EDGAR |
| 2016-11-23 | SIGA | Grant (A) | — | $0 | EDGAR |
| 2016-08-11 | ABIOMED INC (APOL) Delisted | Grant (A) | +1,621 | $0 | EDGAR |
| 2015-09-24 | SIGA | Mixed | +30,000 | -$24.2K | EDGAR |
| 2015-09-03 | SIGA | Mixed | +30,000 | -$26.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.